References
- Hegde U.M., Zuiable A., Ball S., Roter B. L. T. The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: A clinical and serological evaluation in 508 patients. Clin. Lab. Haematol. 1985; 7: 7–16
- Helmerhorst F.M., van Leeuwen E.F., Pegels J.G., Van-der Plas-van Dalen C., Eengelfriet C.P., von Dem Bome Kr A. E. G. Primary and secondary autoimmune thrombocytopenia: A serological and clinical analysis. Stand. J. Haematol. 1982; 28: 319–328
- Jones S.E. Autoimmune disorders and malignant lymphoma. Cancer 1973; 31: 1092–1098
- Rudders R.A., Aisenberg A.C., Schiller A.L. Hodgkin's disease presenting as “Idiopathic” thrombocytopenic purpura. Cancer 1972; 30: 220–230
- Fink K., Al-Mondhiry H. Idiopathic thrombocytopenic purpura in lymphoma. Cancer 1976; 37: 1999–2004
- Rubenstein D.B., Longo D.L. Peripheral destruction of platelets in chronic lymphocytic leukemia: Recognition, prognosis and therapeutic implications. Am. J. Med. 1981; 71: 729–732
- Kaden B.R., Rosse W.F., Hauch T.W. Immune thrombocytopenia in lymphoproliferative diseases. Blood 1979; 53: 545–555
- Wadell C.C., Cimo P.L. Idiopathic thrombocytopenic purpura occuring in Hodgkin's disease after splenectomy: Report of two cases and review of the literature. Am. J. Hematol. 1979; 7: 381–387
- Jackson S.R., Carter J.M. Platelet volume: Laboratory measurement and clinical application. Blood Rev. 1993; 7: 104–113
- Kiefel V., Becker T., Mueller-Eckhardt G., et al. Platelet survival determined with 51Cr versus 111 In. Klin. Wochenschr. 1985; 63: 84–89
- Kienast J., Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelet: A diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990; 75: 116–121
- Kuznetsov A.I., Ivonov A.L., Idelson L.I., Mazurov A.V. Mechanisms of thrombocytopenia in patients with lymphoproliferative diseases. Eur. J. Haematol. 1992; 49: 113–118
- Berchtold P., McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309–2317
- Carey R.W., McGinnis A., Jacobson B.M., Carvalho A. Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia: Management with sequential splenectomy and chemotherapy. Arch. Intern. Med. 1976; 136: 62–66
- Ebbe S., Wittels B., Dameshek W. Autoimmune thrombocytopenic purpura (TTP' type) with chronic lymphocytic leukemia. Blood 1962; 19: 23–37
- Hale G., Xia M.-Q., Tighe H.P., Dyer M. J. S., Waldmann H. The CAMPATH-1 antigen (CDw52). Tissue Antigens 1990; 35: 118–127
- Dyer M. J. S., Hale G., Marcus R., Waldmann H. Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies. Leukemia and Lymphoma 1990; 2: 179–193
- Isaacs J.D., Watts R.A., Hazleman B.L., et al. Humanised monoclonal antibody treatment for rheumatoid arthritis. Lancet 1992; 340: 748–752
- Hale G., Bright S., Chumbley G., et al. Removal of T cells from bone marrow for transplantation: A monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873–882
- Lim S.H., Hale G., Marcus R.E., Waldmann H., Baglin T.P. CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. Br. J. Haematol. 1993; 84: 542–544